Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (191-200 of 457) with videos related to

Pageof 46
Sort By:
Leukemia & Lymphoma|February 7, 2020
Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based surveyAlexander B Pine, Nora Chokr, Maximilian Stahl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 3, 2015
Correlation of Pain and Fluoride Concentration in Allogeneic Hematopoietic Stem Cell Transplant Recipients on VoriconazoleMegan R Barajas, Kristen B McCullough, Julianna A Merten, et al.
Blood|March 25, 2006
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993Hillard M Lazarus, Susan M Richards, Raj Chopra, et al.
Transplantation and Cellular Therapy|February 11, 2023
Comparison of Pretransplantation Prediction Models for Nonrelapse Mortality in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell TransplantationAldo A Acosta-Medina, Anmol Baranwal, Isla McKerrow Johnson, et al.
Haematologica|October 30, 2025
Patient-centered care strategies for Jehovah's Witnesses with acute leukemia and high-grade myeloid neoplasmsJabra Zarka, Aref Al-Kali, Hassan B Alkhateeb, et al.
Blood Cancer Journal|November 21, 2020
Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemiaPrateek Pophali, Aasiya Matin, Abhishek A Mangaonkar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 19, 2012
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow TransplantationPaul J Martin, J Douglas Rizzo, John R Wingard, et al.
Leukemia Research|March 3, 2009
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosisRuben A Mesa, Susan Schwager, Deepti Radia, et al.
Ejhaem|October 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocolNeil D Palmisiano, Ju-Whei Lee, David F Claxton, et al.
Transplantation and Cellular Therapy|July 5, 2023
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid LeukemiaMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.
Pageof 46

Showing results (191-200 of 457) with videos related to

Sort By:
Pageof 46
Leukemia & Lymphoma|February 7, 2020
Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based surveyAlexander B Pine, Nora Chokr, Maximilian Stahl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 3, 2015
Correlation of Pain and Fluoride Concentration in Allogeneic Hematopoietic Stem Cell Transplant Recipients on VoriconazoleMegan R Barajas, Kristen B McCullough, Julianna A Merten, et al.
Blood|March 25, 2006
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993Hillard M Lazarus, Susan M Richards, Raj Chopra, et al.
Transplantation and Cellular Therapy|February 11, 2023
Comparison of Pretransplantation Prediction Models for Nonrelapse Mortality in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell TransplantationAldo A Acosta-Medina, Anmol Baranwal, Isla McKerrow Johnson, et al.
Haematologica|October 30, 2025
Patient-centered care strategies for Jehovah's Witnesses with acute leukemia and high-grade myeloid neoplasmsJabra Zarka, Aref Al-Kali, Hassan B Alkhateeb, et al.
Blood Cancer Journal|November 21, 2020
Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemiaPrateek Pophali, Aasiya Matin, Abhishek A Mangaonkar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 19, 2012
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow TransplantationPaul J Martin, J Douglas Rizzo, John R Wingard, et al.
Leukemia Research|March 3, 2009
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosisRuben A Mesa, Susan Schwager, Deepti Radia, et al.
Ejhaem|October 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocolNeil D Palmisiano, Ju-Whei Lee, David F Claxton, et al.
Transplantation and Cellular Therapy|July 5, 2023
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid LeukemiaMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.
Pageof 46